82 results
8-K
EX-10.1
ADAP
Adaptimmune Therapeutics Plc
29 Jun 23
Departure of Directors or Certain Officers
4:25pm
incapable of exercise (other than by reason of the satisfaction thereof) shall not be included (to the extent that the relevant award has lapsed … ceases to be Connected for one of the following reasons:
death;
disability, injury or ill health (evidenced to the satisfaction of the Board
8-K
EX-10.2
95gi4fvr2i 9t
29 Jun 23
Departure of Directors or Certain Officers
4:25pm
8-K
EX-10.1
vwlcwazk7 kmrcls6
1 Jun 23
Adaptimmune Announces Completion of Strategic Combination with TCR² Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
4:09pm
425
1fyspyumf6oo
30 May 23
Business combination disclosure
4:21pm
8-K
65lqva1
30 May 23
Submission of Matters to a Vote of Security Holders
4:18pm
425
m1jtj831fut zuoy
22 May 23
Business combination disclosure
7:01am
8-K
4n4pqir0phe4l
22 May 23
Other Events
6:59am
8-K
EX-99.1
12aoa7h
12 May 23
Adaptimmune Reports First Quarter Financial Results and Business Update
7:36am
424B3
ul70niuu
20 Apr 23
Prospectus supplement
4:32pm
S-4/A
9tpdatq33pxhtlfnju1
18 Apr 23
Registration of securities issued in business combination transactions (amended)
4:01pm
S-4
tom7j4u4id56qc3
5 Apr 23
Registration of securities issued in business combination transactions
4:40pm